University of Thessaly (UTH)
Μελέτη της ψυχωσεομιμητικής δράσης μη συναγωνιστικών ανταγωνιστών του υποδοχέα NMDA
Abstract
dc:descriptionGlutamate is the most important excitatory amino-acid in the central nervous system. Schizophrenia is a common psychiatric disorder. It has been associated with dysfunction of glutamatergic neurotransmission. Non competitive NMDA receptor antagonists such as phencyclidine (PCP), ketamine and MK-801 produce psychotomimetic effects and cognitive deficits both in humans and rodents when administrated either at sub-anesthetic or anesthetic doses. Nitric oxide (NO) acts as a second messenger in the brain and is believed to be involved in the mechanisms of learning and memory. In the present study the role of the non-competitive NMDA antagonists, ketamine and MK-801, on different types of memory has been investigated. Additionally, we evaluated whether the non-selective NOS inhibitor L-NAME, could reverse memory deficits induced by these NMDA receptor antagonists.Sub-anesthetic doses of ketamine (1 and 3 mg/kg) and MK-801 (0.1 mg/kg) disrupted rats’ spatial and non-spatial recognition memory. Moreover, repeated treatment with sub-anesthetic ketamine (15 mg/kg) impaired rats’ spatial working and reference memory abilities.Anesthetic ketamine (100 mg/kg) disturbed rats’ retrograde and anterograde recognition memory. Further, pre-training administration of anesthetic ketamine produced spatial recognition memory deficits in the rat. Reportedly, in this context, memory recovery seems to be related to the environmental conditions during treatment (hypothermia) and to the type of the behavioral task (spatial vs. non-spatial) used.Administration of the NOS inhibitor L-NAME (1 and 3 mg/kg) counteracted sub- anesthetic and anesthetic ketamine-induced recognition memory deficits. L-NAME (10 mg/kg) attenuated the spatial working memory deficits produced by repeated treatment with sub-anesthetic ketamine. Interestingly, L-NAME administered at 3 mg/kg disrupted rats’ spatial memory abilities.Overall, the present findings confirm the amnesic effect of non competitive NMDA receptor antagonists both at sub-anesthetic and anesthetic doses and indicate that administration of a NOS inhibitor can attenuate NMDA receptor antagonists’ psychotomimetic effects.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Boultadakis, Antonios
- Μπουλταδάκης, Αντώνιος
Subjects
dc:subject × 18Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29430